In this MM+M podcast episode, industry leaders explore how pharma marketers can effectively reach healthcare providers and patients in today’s fragmented media landscape. Featuring insights from National CineMedia (NCM), the discussion covers the challenges of regulatory compliance, audience targeting, and media strategy—highlighting how high-impact channels like cinema are delivering real engagement and measurable results.

National CineMedia (NCM) expands its premium, in-theater video advertising inventory to programmatic buyers through Vistar’s supply-side platform (SSP), creating an additional, highly efficient buying path for brands looking to reach coveted cinema audiences and providing advertisers access to NCM’s suite of data-driven solutions.

National CineMedia partners with Vistar Media to expand programmatic access to cinema ad inventory, offering brands an efficient, data-driven way to reach engaged moviegoers on the big screen through Vistar’s SSP.

NCM and iSpot announced in June that they’re expanding their partnership to provide the first-ever scaled, third-party measurement of in-theater ads, specifically those that run during trailers before a movie begins. For the first time, NCM will integrate its household-level exposure data with iSpot’s unified cross-platform and outcomes-based measurement solutions.

National CineMedia, the largest cinema advertising platform in the US, and cross‑platform TV ad measurement company iSpot, have announced the companies are deepening their partnership – with independent, in‑cinema measurement of advertisements that appear in the trailers before movies begin. The deal marks NCM’s first integration of advertising information with a third‑party measurement provider…

CTV promised advertisers deep engagement and precision targeting—but the reality hasn’t delivered. Viewers face too many choices, ads are often repetitive or ignored, and attention is fragmented. As Catherine Sullivan argues, “This wasn’t innovation.” The tech and infrastructure still aren’t ready to meet the hype.